Cargando…

Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia

Primary hyperchylomicronemia is characterized by marked hypertriglyceridemia exceeding 1,000 mg/dL. It is caused by dysfunctional mutations in specific genes, namely those for lipoprotein lipase (LPL), glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1), apolip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Katsunao, Koseki, Masahiro, Kato, Hisashi, Miyashita, Kazuya, Okada, Takeshi, Kanno, Kotaro, Saga, Ayami, Chang, Jiuyang, Omatsu, Takashi, Inui, Hiroyasu, Ohama, Tohru, Nishida, Makoto, Yamashita, Shizuya, Sakata, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899696/ https://www.ncbi.nlm.nih.gov/pubmed/35185060 http://dx.doi.org/10.5551/jat.63348

Ejemplares similares

Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein
por: Okada, Takeshi, et al.
Publicado: (2021)

Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice
por: Chang, Jiuyang, et al.
Publicado: (2021)

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy
por: Kanno, Kotaro, et al.
Publicado: (2022)

A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice
por: Saga, Ayami, et al.
Publicado: (2022)

Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction
por: Liu, Jingyi, et al.
Publicado: (2019)

Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency
por: Okada, Takeshi, et al.
Publicado: (2018)

Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency
por: Rodríguez-Gutiérrez, Perla Graciela, et al.
Publicado: (2022)

A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
por: Sairyo, Masami, et al.
Publicado: (2018)

Erratum:A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
por: Sairyo, Masami, et al.
Publicado: (2018)

Retinal lipemia as expression of hyperchylomicronemia syndrome
por: Ortiz de Salido-Menchaca, Jon, et al.
Publicado: (2021)

Acute coronary syndrome and postprandial delayed hyperchylomicronemia
por: Okajima, Fumitaka, et al.
Publicado: (2019)

Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)
por: Masuda, Daisaku, et al.
Publicado: (2018)

Functional validation of GPIHBP1 and identification of a functional mutation in GPIHBP1 for milk fat traits in dairy cattle
por: Yang, Jie, et al.
Publicado: (2017)

Deletion of GPIHBP1 causing severe chylomicronemia
por: Rios, Jonathan J., et al.
Publicado: (2011)

Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
por: Masson, Walter, et al.
Publicado: (2023)

GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients
por: Hu, Xuchen, et al.
Publicado: (2019)

A Woman With Hypertriglyceridemia Who Acquired Antibody Against GPIHBP1
por: Hirano, Yuka, et al.
Publicado: (2020)

Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis
por: Birrane, Gabriel, et al.
Publicado: (2019)

Severe hypertriglyceridemia as a cause of necrotizing pancreatitis in a pediatric patient with familial hyperchylomicronemia syndrome: A case report
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2022)

Accelerated Atherogenicity in Tangier Disease: A Case Accompanied by Extensive Atherosclerotic Lesions, Leriche Syndrome and Bleeding Tendency, and Review of the Literature
por: Muratsu, Jun, et al.
Publicado: (2018)

Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency
por: Nyrén, Rakel, et al.
Publicado: (2012)

A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism
por: Young, Stephen G., et al.
Publicado: (2022)

Identification and quantitative mRNA analysis of a novel splice variant of GPIHBP1 in dairy cattle
por: Yang, Jie, et al.
Publicado: (2014)

A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis
por: Jung, Mo Kyung, et al.
Publicado: (2017)

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report
por: Iitake, Chie, et al.
Publicado: (2020)

Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance
por: Surendran, R. Preethi, et al.
Publicado: (2018)

Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report
por: Lin, Min-Huan, et al.
Publicado: (2020)

A homozygous variant in the GPIHBP1 gene in a child with severe hypertriglyceridemia and a systematic literature review
por: Sustar, Ursa, et al.
Publicado: (2022)

Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions
por: Nakaoka, Hajime, et al.
Publicado: (2013)

Correction: Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions
por: Nakaoka, Hajime, et al.
Publicado: (2013)

Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue
por: Kroupa, Olessia, et al.
Publicado: (2012)

The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain
por: Mysling, Simon, et al.
Publicado: (2016)

GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity
por: Kristensen, Kristian Kølby, et al.
Publicado: (2021)

Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men
por: Matsumoto, Ryutaro, et al.
Publicado: (2019)

The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding
por: Mysling, Simon, et al.
Publicado: (2016)

Case Report: Successful Management of a 29-Day-Old Infant With Severe Hyperlipidemia From a Novel Homozygous Variant of GPIHBP1 Gene
por: Liu, Shu, et al.
Publicado: (2022)

Acute Subdural Hematoma Complicating Heparin-induced Thrombocytopenia: A Case Report
por: MIYAUCHI, Tsubasa, et al.
Publicado: (2021)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

Comparative studies of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1: evidence for a eutherian mammalian origin for the GPIHBP1 gene from an LY6-like gene
por: Holmes, Roger S., et al.
Publicado: (2011)

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfnq1aa97krgqrju8cn3phhucq